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Abstract
This multicenter cohort study on embryo assessment and outcome data from 11,744 IVF/ICSI
cycles with 104,830 oocytes and 42,074 embryos, presents the effect of women’s age on
oocyte, zygote, embryo morphology and cleavage parameters, as well as cycle outcome mea-
sures corrected for confounding factors as center, partner’s age and referral diagnosis. Cycle
outcome data confirmed the well-known effect of women’s age. Oocyte nuclear maturation and
proportion of 2 pro-nuclear (2PN) zygotes were not affected by age, while a significant increase
in 3PN zygotes was observed in both IVF and ICSI (p<0.0001) with increasing age. Maternal
age had no effect on cleavage parameters or on the morphology of the embryo day 2 post
insemination. Interestingly, initial hCG value after single embryo transfer followed by ongoing
pregnancy was increased with age in both IVF (p = 0.007) and ICSI (p = 0.001) cycles. For the
first time, we show that a woman’s age does impose a significant footprint on early embryo
morphological development (3PN). In addition, the developmentally competent embryos were
associated with increased initial hCG values as the age of the women increased. Further stud-
ies are needed to elucidate, if this increase in initial hCG value with advancing maternal age is
connected to the embryo or the uterus.
Introduction
It is well-recognized that the fertility potential of women decreases with increasing age. The
decline in female reproductive capacity with increasing age has two main causes: Gradual
depletion of oocytes from the ovary, and a decrease in oocyte quality [1].
A fully developmentally competent oocyte is an oocyte that through oogenesis achieves the
ability to resume meiosis, become fertilized with a single spermatozoa, de-condense the sperm
head, create two pronuclei (PN), pass cleavage stages, undergo maternal-to-embryonic
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transition, reach the blastocyst stage, hatch, and establish a pregnancy that results in the birth
of a healthy baby [2]. That the decrease in the oocyte developmental competence contributes
to lower fecundity with increasing age has been shown by achieving comparable pregnancy
rates between young women undergoing in vitro fertilization (IVF) treatment with their own
oocytes and older women (>40 years) in IVF treatment with oocytes donated by the younger
women [3].
The aneuploidy rates in both oocytes and in vitro produced embryos increase with increas-
ing female age [4–6]. In a recent study using array comparative genomic hybridization of polar
bodies, the aneuploidy rate increased from 47% among women aged 27–37 years to 78%
among those aged 38–47 years [6].
We have previously shown that there is a significant effect of age on the expression of genes
involved in cell cycle regulation (e.g. microtubule-based processes, chromatin assembly, M-
phase of the meiosis) in oocytes in metaphase II (MII) from women undergoing IVF or intra-
cytoplasmic sperm injection (ICSI) treatment [7]. These findings supported that meiosis and
cell cycle regulation mechanisms may be affected by increasing age of the woman.
In IVF and ICSI treatment, the oocytes, zygotes, and embryos are evaluated by cleavage rate
and morphological parameters reported to correlate with favorable outcome, following the
ALPHA and ESHRE consensus parameters [8]. It has previously been found that a summed
score for cleavage stage embryo quality is not affected by women’s age [9,10], but it is not
known if age influences the individual parameters and hence the more detailed cleavage
events.
The aim of this study was to investigate whether individual oocyte, zygote, and embryo
morphology and cleavage parameters of the developing embryo, as well as outcome measures
are influenced by the age of the woman undergoing IVF or ICSI treatment.
Materials and methods
Design
Multicenter, historical cohort study.
Data and patients
The data was collected from 5 Danish fertility clinics’ (4 public and 1 private clinic) databases
(FertiClient, CellCura Solutions A/S, Copenhagen, Denmark). In the dataset received for anal-
ysis from the clinics’ databases, subjects could not be identified, neither directly nor through
identifiers linked to the subjects and, therefore, no institutional review board or ethics com-
mittee approval was needed according to Danish law.
All IVF and ICSI cycles following controlled ovarian stimulation (COS), except cycles with
donor gametes or pre-implantation genetic diagnostic, performed during 2007–2010, were
included. The regimens for COS included standard long agonist and short antagonist proto-
cols with either recombinant FSH or highly purified menotrophin. Ovulation was induced by
hCG or GnRH agonist administration when leading 2 follicles reached 17 mm, and oocyte
pick up was performed 34–36 hours later. All five clinics used the same static time frames for
assessing the various oocyte and embryo evaluation parameters, even though ‘early cleavage’
was only used in 2 centers (representing 37% of the cycles), and only one center used routine
registration of multinuclear blastomeres (representing 20% of the cycles). All centers routinely
transferred 1 or 2 embryos on day 2. Within centers, the in vitro procedures as well as the luteal
phase support with progesterone and the method for hCG analysis were identical throughout
the age groups. Potential influence of variation between centers regarding COS regimens and
Female age and embryo cleavage
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in vitro procedures on data is addressed in the statistical analysis model by stratification for
center.
IVF and ICSI. The methods of insemination include differences in handling and induce
differences in timing of cleavages post insemination and hence difference in timing for assess-
ing the cleavage events has been recommended [11]. However, the routine embryo assess-
ments in the 5 clinics did not include differential timing in regard to insemination technique
and, therefore, we chose to split the embryo assessment data into IVF and ICSI.
In ICSI cycles, only MII oocytes were inseminated, while the immature oocytes were
discarded.
Parameters. The data collected included the following parameters: Woman’s age, part-
ner’s age, referral diagnosis, number of cycles, cycle type (IVF; ICSI), number of oocytes (num-
ber of cumulus-oocyte-complexes at oocyte retrieval 34–36 hours after ovulation trigger),
number of MII oocytes (ICSI only: 38–40 hours after ovulation trigger), fertilization (0 PN;
1PN; 2PN;3PN: 18–20 hours after insemination), early cleavage (PN number; cleavage: 24–
26 hours after insemination), number of blastomeres (42–44 hours after insemination), frag-
mentation (0%; >0–10%; >10–25%; > 25%), blastomere size (even; uneven: data from 2- and
4-cell embryos only: 42–44 hours after insemination), and presence of multinuclearity
(embryos with blastomere(s) with more than 1 nucleus or micronuclei, which are smaller
nuclear structures (see Luzhna et al 2013(ref. 30)): 42–44 hours after insemination) in one or
more blastomeres. Furthermore, number of embryos transferred on day 2 (1; 2), hCG in blood
plasma (initial hCG value) (IU/L; positive (>25IU/L); negative (<25IU/L): 14 days after trans-
fer), and number of gestational sacs and fetal hearts (0; 1; 2: week 7–8 of gestation) were
extracted from the databases.
Primary endpoints are MII rate (ICSI) (number of MII / number of oocytes), fertilization
rates (number of 2PN zygotes / number of oocytes inseminated; number of 1PN zygotes /
number of oocytes inseminated; number of3PN zygotes / number of oocytes inseminated),
cleavage rate (number of 2PN zygotes cleaved / number of 2PN zygotes), early cleavage rates
(number of 2PN zygotes early cleaved / number of 2PN zygotes; number of 0PN zygotes early
cleaved / number of 0PN zygotes (0PNs were followed to ensure observations of zygotes where
PN had faded before the fertility check)), 2-cell rate (number of 2PN zygotes being 2-cells at
day 2 / number of 2PN zygotes), 4-cell rate (number of 2PN zygotes being 4-cells at day 2 /
number of 2PN zygotes), rate of 4-cells with moderate to high (>10%) fragmentation, 4-cells
with uneven sized blastomeres at day 2, and rate of 4-cells with one or more multinuclear
blastomeres.
Secondary endpoints are number of oocytes, cycle outcomes as embryo transfer (ET) rate
(number of embryo transfers / number of oocyte retrievals), single embryo transfer (SET) rate
(number of ETs with a single embryo / total number of ETs), positive hCG rate per embryo
transfer, implantation rate (number of gestational sacs / number of embryos transferred), clin-
ical intra uterine pregnancy rate (number of pregnancies with gestational sac / ET), and ongo-
ing pregnancy rate (number of pregnancies with fetal heart beat / ET). Initial value in hCG in
cycles with single embryo transfer resulting in ongoing pregnancy was evaluated in a post-hoc
analysis.
For the data set see S1 Table.
Statistical methods
Data are presented as counts and percentages or as means, where appropriate. Parameters
from different levels of nesting were analyzed for age differences. Parameters regarding single
oocytes/embryos were nested within cycles, which in turn were nested within women.
Female age and embryo cleavage
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Parameters describing cycles, e.g. number of oocytes extracted, were nested within woman
alone. Finally, some parameters show no nesting at all, such as partner’s age at first cycle. The
parameters under evaluation represented counts and binary data. We, therefore, chose to use
generalized linear models with random effects according to nesting levels, thus allowing for
the correlated nature of the data, to model the outcomes, taking into account potentially con-
founding variables, including treatment center, partner’s age (categorical: <30, 30–50,>50
years), and referral diagnosis. This comprises mixed logistic regression for binary data report-
ing Adjusted Odds Ratios (OR), and mixed Poisson regression for count data reporting inten-
sity rate ratios. R-2.15 [12] was used for data-management and statistical analysis. The lme4
package [13] was used for fitting the multivariate generalized mixed models. Age differences
were analyzed by means of age groups, as well as applying a test for trend. Treatment centers
were considered a fixed effect in all multivariate analyses. Total FSH dose was considered a
potential intermediate variable and was therefore not adjusted for. To account for potential
effect modification/interaction, analyses for main outcomes were stratified by center. Missing
data was considered missing completely at random and incomplete cases thus removed from
analysis. In one treatment center (representing 27% of the cycles), data on referral diagnosis
were missing, and subsequently coded as “other”. P-values under 0.05 were considered statisti-
cally significant.
Results
In total, 11,744 cycles (5650 IVF and 6094 ICSI) were included in the analysis representing
104,830 oocytes and 42,074 embryos.
Partner’s age and infertility diagnosis
Partner’s mean age and referral diagnosis by female age groups are shown in Table 1. Both
were significantly correlated to female age, and hence the subsequent analyses were adjusted
for these confounding variables.
Cycle outcome. Table 2 shows the outcome of IVF and ICSI cycle in regard to female age.
The number of cycles per woman increased with increasing age. Furthermore, the number of
oocytes retrieved decreased with increasing age. For both IVF and ICSI cycles, no significant
age dependency was found in the chance to have embryo transfer after oocyte retrieval, while
the rate of single embryo transfers significantly decreased with increasing age (p<0.0001). A
significant decrease in cycle clinical outcome parameters (positive hCG, clinical intrauterine
pregnancy, as well as ongoing pregnancy), were present with increasing age of the woman
(p<0.0001).
Table 1. Partner’s age and referral diagnosis in relation to the age of the women undergoing IVF or ICSI.
Female age group (years)
18–24 25–29 30–35 36–40 41–46 p-value p-value, Test for trend#
Partner’s age (mean years) 28.3 32.1 35.1 38.7 42.1 <0.0001 <0.0001
Tubal factor 16 (5.7%) 107 (4.4%) 316 (7.0%) 455 (11.9%) 36 (5.1%) <0.0001 0.16
Male factor 123 (43.5%) 921 (38.2%) 1571 (34.7%) 1099 (28.7%) 192 (27.2%) <0.0001 <0.0001
Anovulation 29 (9.2%) 192 (8.0%) 276 (6.1%) 167 (4.4%) 16 (2.3%) <0.0001 <0.0001
Endometriosis 3 (1.1%) 77 (3.2%) 135 (3.0%) 88 (2.3%) 3 (0.4%) <0.0001 <0.0001
Other 115 (40.6%) 1112 (46.2%) 2225 (49.2%) 2015 (52.7%) 458 (65.0%) <0.0001 0.00012
p<0.05 is considered significant.
#Modeling age groups in a linear fashion.
https://doi.org/10.1371/journal.pone.0172456.t001
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The initial value in hCG in IVF and ICSI cycles with single embryo transfer resulting in
ongoing pregnancy (ICSI: 374; IVF: 429) is shown in Fig 1. In both IVF and ICSI cycles, the
initial value in hCG increased with increasing age of the woman. This analysis was not strati-
fied for referral diagnosis due to limited size of the data set.
Morphology and cleavage rate parameters
Table 3 shows the oocyte, zygote, and embryo evaluations parameters.
The maturity of the oocytes, evaluated at the time of ICSI, was not influenced by the age
showing a constant MII rate around 80% throughout the dataset.
The analysis to reveal a potential age dependent trend in 2PN fertilization rate did not show
a significant effect in either IVF or ICSI cycles (Table 3). However, the p-value indicated a dif-
ference in 2PN rates between the age groups. In ICSI cycles, the youngest age (18–24 years)
group (OR = 1) showed lower rate as compared to the groups 25–29, 30–34 and 35–39 years
(all OR significantly >1). In IVF cycles, the youngest age group showed a non-significant dif-
ference in rate compared to all older age groups. As the scope of the study was to address a
general effect of age, further pairwise comparisons between individual groups were not
performed.
In both IVF and ICSI, the rates of 3PN zygotes were significantly increased with age (p-
value test for trend, p<0.0001). In ICSI, the prevalence of 1PN zygotes decreased with increas-
ing age, although the test for trend did not reach statistical significance (p-value test for trend,
p = 0.08). For the 1PN rate in IVF cycles, no multivariate analysis was available due to lack of
variation.
The rates of unequally sized blastomeres in 4-cell embryos were unaltered by female age
representing about 35% of the 4-cell embryos.
Table 2. The effect of women’s age on treatment practice and clinical outcome measures after IVF and ICSI.
Female age group (years)
Measurements Cycle 18–24 25–29 30–34 35–39 40–46 p-value p-value, Test for
trend#
No. of cycles per age group 283
(2.4%)
2409
(20.5%)
4523
(38.5%)
3824
(32.6%)
705
(6%)
No. of cycles per woman (mean) 1.66 1.74 1.83 1.94 2.07 <0.0001 <0.0001
No. of oocytes retrieved per cycle
(mean)
9.63 9.82 9.40 8.03 7.41 <0.001 <0.0001
Embryo Transfer (%) IVF 86.1 90.5 89.9 90.4 90.2 >0.1 0.86
ICSI 92.6 91.8 90.3 86.0 84.5 >0.1 0.37
Single embryo transfer rate (%) IVF 54.5 52.3 43.8 33.2 27.1 <0.0001 <0.0001
ICSI 54.5 48.2 40.6 36.0 31.2 <0.0001 <0.0001
Positve hCG (%) IVF 38.9 40.0 38.6 32.7 17.4 <0.0001 <0.0001
ICSI 41.7 38.9 35.3 31.2 16.5 <0.0001 <0.0001
Clinical intrauterine pregnancy (%) IVF 30.6 33.6 31.1 25.9 12.3 <0.0001 <0.0001
ICSI 37.7 32.8 28.9 24.9 13.5 <0.0001 <0.0001
Ongoing pregnancy (%) IVF 29.6 31.1 28.9 22.9 9.6 <0.0001 <0.0001
ICSI 36.0 30.1 26.6 22.0 10.1 <0.0001 <0.0001
Implantation rate (%) IVF 24.66 25.31 23.33 17.79 8.51 <0.0001 <0.0001
ICSI 29.03 24.43 21.59 18.47 9.85 <0.0001 <0.0001
p<0.05 is considered significant.
#Modeling age groups in a linear fashion.
https://doi.org/10.1371/journal.pone.0172456.t002
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No significant differences in fragmentation were present at the 4-cell stage. However, a sys-
tematic tendency towards increased fragmentation at the 4-cell stage in IVF embryos was
observed, although not significant (p-value test for trend, p = 0.06).
Multinuclear blastomeres were found in 40–45% of 2-cell and 3-cell stage embryos (data
not shown) in both IVF and ICSI, while only 7–11% of 4-cell stage embryos after IVF and ICSI
contained multinuclear blastomeres. The rate of multinuclear embryos was not influenced by
the age of the woman (data for 2- and 3-cells are not shown, for 4-cells please see Table 3).
The cleavage rate (approximately 90%) per 2PN-zygote was not influenced by age (IVF: test
for trend p = 0.16; ICSI: test for trend p = 0.33, these data are not shown in Table 3). For ICSI
zygotes, a reduced rate in early cleavage was present, albeit insignificant (test for trend
p = 0.06) with increasing age, while no trend was present for IVF (test for trend p = 0.92).
Regarding the rate of 0PN zygotes, cleaving was also decreased by increasing female age after
ICSI (test for trend p = 0.02), while no age effect was found for this rate in 0PN zygotes after
IVF. For ICSI, no trend in age-induced 2- or 4-cell rate (day 2) was present, while a statistically
insignificant tendency towards an increase in 2-cell rate (test for trend p = 0.07), and reduction
in 4-cell rate (test for trend p = 0.07) were present in the IVF embryos.
The analysis stratified by center (number of oocytes, 3PN prevalence and initial hCG value)
showed homogeneous results for all strata (data not shown).
Re-analysis of the data without the youngest age group was performed to ensure that the
observed effect of age remained if the youngest age group was excluded. Test for trends in this
re-analysis confirmed the age effect and level of significance in all parameters in Tables 2 and
Fig 1. The initial rise* in hCG after single embryo transfer in IVF and ICSI treatments resulting in ongoing clinical pregnancy with fetal heart
beat (week 7–8) increases significantly with increasing women’s age. *hCG in blood plasma 14 days after day-2 transfer. Number of observations:
IVF: 429; ICSI: 374. # Modeling age groups in a linear fashion.
https://doi.org/10.1371/journal.pone.0172456.g001
Female age and embryo cleavage
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Table 3. Effect of women’s age on key morphology and cleavage evaluation parameters in oocyte, zygote and embryo in 5,650 IVF and 6,094 ICSI
cycles.
Female age group (years)
Evaluation-parameter Cycle 18–24 25–29 30–34 35–39 40–46 p-value p-value, Test for
trend#
MII ratea ICSI % 79.4 80.0 79.1 79.5 79.2
OR 1 0.96 (0.74–
1.24)
0.95 (0.73–
1.24)
0.98 (0.74–
1.28)
0.82 (0.57–
1.17)
0.73 0.69
Fertilization-rate, 2PNb IVF % 55.6 56.4 56.1 58.5 53.8
OR 1 0.83 (0.63–
1.08)
0.63 (0.63–
1.08)
0.93 (0.71–
1.22)
0.79 (0.58–
1.08)
0.02 0.22
ICSI % 53.1 58.8 58.1 59.3 58.2
OR 1 1.32 (1.07–
1.61)
1.29 (1.05–
1.58)
1.31 (1.06–
1.62)
0.99 (0.75–
1.31)
0.007 0.90
Fertilization-rate, 1PNb IVF* % 3.9 4.1 3.4 3.4 3.3
OR NA NA NA NA NA NA NA
ICSI % 4.9 3.3 3.1 3.2 2.6
OR 1 0.74 (0.64–
0.86)
0.75 (0.64–
0.88)
0.70 (0.59–
0.82)
0.90 (0.72–
1.12)
<0.0001 0.08
Fertilization-rate,3PNb IVF % 5.15 4.4 4.7 4.9 6.8
OR 1 0.92 (0.64–
1.32)
1.15 (0.80–
1.65)
1.24 (0.86–
1.78)
1.71 (1.13–
2.57)
<0.0001 <0.0001
ICSI % 2.4 1.7 1.7 2.8 3.4
OR 1 0.80 (0.49–
1.31)
0.97 (0.59–
1.60)
1.31 (0.79–
2.18)
1.69 (0.91–
3.14)
0.0003 <0.0001
Earlycleavage in 2PN
zygotesc**
IVF % 25.6 24.6 23.7 22.8 27.3
OR 1 0.88 (0.42–
1.83)
0.88 (0.43–
1.84)
0.88(0.42–
1.85)
0.90 (0.95–
2.29)
1.00 0.92
ICSI % 33.2 29.7 26.6 22.5 24.7
OR 1 0.90 (0.48–
1.66)
0.81 (0.43–
1.54)
0.62 (0.32–
1.21)
0.78 (0.25–
2.40)
0.38 0.06
Cleavage/0PNd IVF % 12.7 14.4 11.8 12.7 13.5
OR 1 0.64 (0.12–
3.44)
0.46 (0.08–
2.50)
0.49 (0.09–
2.76)
0.69 (0.09–
5.11)
0.15 0.18
ICSI % 14.4 13.3 11.7 9.6 12.3
OR 1 0.74 (0.13–
4.22)
0.55 (0.09–
3.36)
1.08 (0.17–
7.02)
2.17 (0.19–
24.8)
1.00 0.02
2-cell rate/2PNd IVF % 10.5 16.4 17.7 20.0 18.7
OR 1 1.55 (0.95–
2.54)
1.71 (1.04–
2.79)
1.88 (1.14–
3.08)
1.45 (0.82–
2.55)
0.35 0.07
ICSI % 19.0 18.4 20.7 20.2 22.8
OR 1 1.03 (0.69–
1.54)
1.25 (0.83–
1.88)
1.09 (0.71–
1.66)
1.21 (0.71–
2.05)
0.22 0.58
4-cell rate/2PNd IVF % 42.9 44.7 44.6 41.7 41.8
OR 1 0.82 (0.55–
1.23)
0.79 (0.53–
1.18)
0.77 (0.51–
1.16)
0.60 (0.37–
0.96)
0.24 0.07
ICSI % 46.3 43.6 41.9 41.1 41.2
OR 1 0.91 (0.66–
1.26)
0.82 (0.59–
1.15)
0.89 (0.63–
1.25)
0.73 (0.47–
1.15)
0.44 0.40
Fragmentation>10%, 4celld IVF % 26.8 32.6 31.5 34.1 34.1
OR 1 1.17 (0.67–
2.05)
1.14 (0.65–
2.01)
1.42 (0.80–
2.53)
1.33 (0.68–
2.60)
0.21 0.06
ICSI % 35.5 34.4 34.0 34.7 32.7
(Continued )
Female age and embryo cleavage
PLOS ONE | https://doi.org/10.1371/journal.pone.0172456 April 19, 2017 7 / 12
3. Likewise, for the initial hCG value after SET of a competent embryo the trend was con-
firmed for IVF (p = 0.03) and ICSI (p = 0.06).
Discussion
This is the first report on the influence of age on the morphology of the early human embryo.
The increase in prevalence of 3PN zygotes is observed in both IVF and ICSI with increasing
age, which may suggest that the background for the increase in 3PN is a compromised ability
to extrude the second polar body, rather than compromised polyspermic block. Considering
the 3PN zygote as the ultimate incompetence in 2nd meiosis, the increase in the 3PN preva-
lence with increasing age may reflect the underlying general insufficient function of the mei-
otic metaphase spindles and affected expression of genes related to M-phase of meiotic cell
cycle in the aged mammalian [14] and human oocytes [7], respectively. The age response in
3PN tends to be u-shaped as do several of the outcome measures with the youngest group of
women (18–25 years) showing compromised performance. Recent reviews report the same u-
shaped tendency in aneuploidy rate in human assisted reproductive technology blastocysts
[15] and clinical outcome [16] additionally indicating that the 3PN prevalence may relate to
compromised meiotic competence in the cohort of oocytes. However, it cannot be excluded
that age also affects the mechanism of the polyspermic block, as we did not have data on the
number of polar bodies 18–20 hours post insemination.
Table 3. (Continued)
Female age group (years)
Evaluation-parameter Cycle 18–24 25–29 30–34 35–39 40–46 p-value p-value, Test for
trend#
OR 1 0.90 (0.58–
1.40)
1.00 (0.63–
1.57)
1.06 (0.66–
1.71)
1.05 (0.55–
1.99)
0.76 0.25
Blastomere size Unequal,
4-celld
IVF % 35.2 33.5 32.1 35.9 27.8
OR 1 0.85 (0.59–
1.21)
0.75 (0.52–
1.07)
0.85 (0.59–
1.22)
0.65 (0.41–
1.02)
0.07 0.51
ICSI % 34.8 38.4 37.9 38.7 27.5
OR 1 1.03 (0.74–
1.44)
1.02 (0.72–
1.44)
0.93 (0.65–
1.33)
0.77 (0.46–
1.27)
0.48 0.14
Multinuclearity4-celld*** IVF % 9.2 7.1 7.7 8.3 6.9
OR 1 0.70 (0.28–
1.73)
0.68 (0.28–
1.68)
0.80 (0.32–
1.99)
0.58 (0.14–
2.35)
0.81 0.88
ICSI % 10.8 11.1 9.4 10.9 0
1 0.76 (0.31–
1.87)
0.58 (0.22–
1.50)
0.70 (0.26–
1.85)
NA 0.51 0.58
OR: Adjusted Odds ratio (adjusted for treatment center, partner’s age and referral diagnosis). p<0.05 is considered significant.
#Modeling age groups in a linear fashion.
aDay 0, 38–40 hours after ovulation trigger.
bDay 1, 18–20 hours after insemination.
cDay 1, 24–26 hours after insemination.
dDay 2, 42–44 hours after insemination.
*Multivariate analysis was not possible due to lack of variation.
**Early cleavage was evaluated in two centers only (number of embryos assessed: IVF: 14,214; ICSI: 10,241).
***Blastomere multinuclearity was evaluated in one center only (number of embryos assessed: IVF: 6,623; ICSI: 4,447).
https://doi.org/10.1371/journal.pone.0172456.t003
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Our data on cycle outcome confirmed the well-documented age-induced decline in embryo
competence, while the significantly higher initial value of hCG in both IVF and ICSI singleton
pregnancies following SET with increasing woman’s age is new. If the correlation between age
and a higher level of hCG relies on altered trophectoderm cells or endometrial conditions
needs to be elucidated. Both ploidy and age-related unique changes in human blastocysts
microRNA profile have been reported recently [17]. The present hCG data were not adjusted
for differences in stimulatory regimens used in the cycles, and hence it cannot be excluded that
the observed effect is due to differences in COS which have been shown to influence the gene
expression of the endometrium [18,19].
The constant rate (80%) of nuclear matured oocytes indicates that the age of the woman
does not impair the ovulation’s trigger-induced signal to resume meiosis. This is in contrast to
a recent publication reporting a significantly higher rate of immature oocytes after controlled
ovarian stimulation in women over forty years-of-age as compared to younger women [20];
however, their finding was based on a limited (< 200 cycles) number of observations with no
adjustment for referral diagnosis.
The fertilization rate (2PN) was not influenced by the increasing age of the women in IVF
or ICSI confirming previous findings [9,10]. However, minor variation between age groups
were seen and in ICSI cycles, the youngest age group did show a lower fertilization rate as com-
pared to the other groups. The competence to progress from 2PN to cleavage, showed no cor-
relation with age, while the timing of the first cleavage (early cleavage) in ICSI 2PN zygotes,
however, showed a tendency to be postponed by increasing age of the woman; from 40% of
2PN zygotes being early cleaved in the youngest age group to 25% in the eldest. IVF embryos
had a tendency to increased length between cell cleavages with increasing age of the woman,
having increased and decreased proportion of 2-cell and 4-cell embryos, respectively, at day 2.
Different cleavage parameters being affected by age in IVF and ICSI embryos probably reflects
the difference in timing of the assessment relative to actual fertilization time, rather than differ-
ence in the development of IVF and ICSI zygotes. The post insemination difference in cleavage
timing after IVF and ICSI is well-recognized [11]; thus, splitting of the present embryo evalua-
tion data set into IVF and ICSI probably provided us with more time differentiated picture of
the cleavage events.
Recent studies addressing the effect of age on cleavage stage development showed no associ-
ation between age and a summed score of the embryo at day 2 and 3 [9,10]. Neither of these
studies assessed early cleavage, nor did they analyze prevalence of the various cell stages, which
may explain the discrepancies.
The age-induced impairment of embryo competence is strongly associated with aneuploidy
in human embryos, which originates predominantly from mis-segregation in meiosis [5,6],
and to a minor degree from early mitotic errors [6]. Chavez and colleges (2012) reported
increased duration of the first cytokinesis in human frozen-thawed zygotes, as well as an
increase in length of the second cell cycle in aneuploid as compared to euploid embryos [21].
A delayed early cleavage division has also been confirmed to relate to aneuploidy [22], while a
recent time-lapse study failed to associate ploidy to cleavage stages parameters [23]. The pres-
ent data showing a tendency towards increased time between cell cleavages with increasing
maternal age further supports that the cleavage rate may be associated with chromosomal sta-
tus of the embryo. If the delay in timing of events starts already at the 1st meiotic division is
not known. However, no major delay seems to be present, since the MII rate was independent
of age. The 2nd meiotic division may be influenced by age, since a recent publication compar-
ing two age groups reports increased time to 2nd polar body extrusion after ICSI in women
aged38 years as compared to younger women [24]. This is in line with the effects of age on
initial cleavages in the present study.
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Future time-lapse recordings of oocytes following ICSI will allow detailed registration of
timing of second polar body extrusion over PN appearance, PN fading, and first cleavage, and
reveal if the age-induced delay is established during the meiosis and/or the preparation for the
first mitosis. An increase in anaphase lag in oocyte meiosis with increasing age has already
been shown in mice [25,26].
Previous reports have shown no age [9,10] or aneuploidy [6] dependent effect on summed
morphology score that included blastomere size (even; uneven) without including cell stage
specificity. The present data take the morphology analysis further, and show no association
between maternal age and the blastomere size regularity in 2- and 4-cell embryos, indicating
normal formation of cleavage furrow and cytokinesis during the first cleavages. Time-lapse
studies have elucidated that fragments are generated dynamically during cytokinesis [27,28],
and while failing to associate with euploidy as single parameter, dynamic fragmentation is sug-
gested to correlate to euploidy [21]. In our data, no age effect was found in single time point
fragmentation degree in neither 2-cell (IVF and ICSI), nor 4-cell (ICSI) embryos. However, we
observed a tendency in increased fragmentation rate in the 4-cells after IVF by increasing age
supporting previous findings in IVF embryos day 2 [29]. We speculate that this may reflect an
age-related increase in dynamic fragmentation related to the second cleavage visible in 4-cell
embryos (IVF) in our data set, since the assessment time being closer to the cleavage event
than in the 2-cells, and the 4-cells after ICSI.
The presence of more than one nucleus and/or micronuclei is correlated to disrupted cell
cycle control and genomic instability [30], and in human cleavage stage embryos the frequency
of chromosomally aberrant blastomeres is significantly higher in embryos containing multinu-
clear blastomeres as compared to mononucleated embryos [31]. High rates (40–50%) of multi-
nuclear blastomeres in 2-cell and 3-cell embryos and lower (10%) in 4-cell embryos at day 2
were observed. On neither cell stages, there was an association with age in presence of blasto-
meres with more than 1 nucleus, suggesting that multinuclearity, observed at a single time
point, is unrelated to the age-induced chromosomal instability and impairment of develop-
mental competence.
Our study has several strengths: It is a large multicenter cohort study with prospectively col-
lected data registered in an everyday setting, and hence reflects daily practice. Furthermore, we
performed adjustment for multiple potential confounders.
In contrast to a general low rate of missing data, 27% of ‘referral diagnosis’ data were miss-
ing due to missing data from one center potentially imposing selection bias, which is a poten-
tial weakness of the study. However, the distribution of referral diagnoses is unlikely to differ
from that of the other clinics, considering the fairly homogeneous population in Denmark.
In conclusion, while the MII rate and 2PN rate were unaffected, age does induce a signifi-
cant effect on the prevalence of 3PN zygotes in both IVF and ICSI with increasing age, which
may represent a compromised meiotic spindle function. The present large-scale study showed
that in terms of individual static embryo evaluation parameters of embryo cleavage rate and
morphology, the age-associated changes are primarily subtle. There was a tendency towards
increased length between the early cell cleavages in both IVF and ICSI, and an increased frag-
mentation (in IVF only), which is in line with affected cell cycle and the age-related dominat-
ing symptom: aneuploidy. Our data on final outcome measures, such as implantation rate and
ongoing pregnancy, confirmed the significant effect of age, however, the effect of women´s age
on the initial hCG value after SET of competent embryos is new. Further studies are needed to
elucidate, if the increase in initial hCG value with advancing maternal age is connected to the
embryo or the uterus.
Female age and embryo cleavage
PLOS ONE | https://doi.org/10.1371/journal.pone.0172456 April 19, 2017 10 / 12
Supporting information
S1 Table. Data Groendahl et al. csv.
(XLS)
Author Contributions
Conceptualization: MLG JB IEA JGL USK PL.
Data curation: MR MLG.
Formal analysis: SL.
Funding acquisition: MLG.
Investigation: MLG.
Methodology: MLG SL.
Project administration: MLG.
Resources: MLG JB.
Writing – original draft: MLG SC SL.
Writing – review & editing: USK IEA PL JGL.
References
1. Tatone C, Amicarelli F, Carbone MC, Monteleone P, Caserta D, Marci R, et al. (2008) Cellular and
molecular aspects of ovarian follicle ageing. Hum Reprod Update 14: 131–142. https://doi.org/10.1093/
humupd/dmm048 PMID: 18239135
2. Armstrong DT (2001) Effects of maternal age on oocyte developmental competence. Theriogenology
55: 1303–1322. PMID: 11327686
3. Navot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandler B, et al. (1991) Poor oocyte quality
rather than implantation failure as a cause of age-related decline in female fertility. Lancet 337: 1375–
1377. PMID: 1674764
4. Handyside AH (2012) Molecular origin of female meiotic aneuploidies. BBA—Mol Basis Disease 1822:
1913–1920.
5. Kuliev A, Zlatopolsky Z, Kirillova I, Spivakova J, Cieslak Janzen J (2011) Meiosis errors in over 20,000
oocytes studied in the practice of preimplantation aneuploidy testing. Reprod Biomed Online 22: 2–8.
https://doi.org/10.1016/j.rbmo.2010.08.014 PMID: 21115270
6. Fragouli E, Alfarawati S, Spath K, Jaroudi S, Sarasa J, Enciso M, et al. (2013) The origin and impact of
embryonic aneuploidy. Hum Genet 132: 1001–1013. https://doi.org/10.1007/s00439-013-1309-0
PMID: 23620267
7. Grondahl ML, Andersen CY, Bogstad J, Nielsen FC, Meinertz H, Borup R (2010) Gene expression pro-
files of single human mature oocytes in relation to age. Hum Reprod 25: 957–968. https://doi.org/10.
1093/humrep/deq014 PMID: 20147335
8. Alpha Scientists in Reproductive Medicine and Eshre Special Interest Group of Embryology (2011) The
Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod
26: 1270–1283. https://doi.org/10.1093/humrep/der037 PMID: 21502182
9. Stensen MH, Tanbo T, Storeng R, Byholm T, Fedorcsak P (2010) Routine morphological scoring sys-
tems in assisted reproduction treatment fail to reflect age-related impairment of oocyte and embryo
quality. Reprod Biomed Online 21: 118–125. https://doi.org/10.1016/j.rbmo.2010.03.018 PMID:
20452822
10. Yan JH, Wu KL, Tang R, Ding LL, Chen ZJ (2012) Effect of maternal age on the outcomes of in vitro fer-
tilization and embryo transfer (IVF-ET). Sci China Life Sci 55: 694–698. https://doi.org/10.1007/
s11427-012-4357-0 PMID: 22932885
11. Lundin K, Bergh C, Hardarson T (2001) Early embryo cleavage is a strong indicator of embryo quality in
human IVF. Hum Reprod 16: 2652–2657. PMID: 11726590
Female age and embryo cleavage
PLOS ONE | https://doi.org/10.1371/journal.pone.0172456 April 19, 2017 11 / 12
12. R Core Team (2014), R: A language and environment for statistical computing. R Foundation for Statis-
tical Computing, Vienna, Austria, http://wwwR-projectorg/.
13. Bates D, Maechler M, Bolker B, Walker S (2014) lme4: Linear mixed-effects models using Eigen and
S4. R package version 1.1–7. http://CRANR-projectorg/package=lme4.
14. Howe K, FitzHarris G (2013) Recent insights into spindle function in mammalian oocytes and early
embryos. Biol Reprod 89: 71. https://doi.org/10.1095/biolreprod.113.112151 PMID: 23966320
15. Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, et al. (2014) The nature of
aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm
biopsies evaluated with comprehensive chromosomal screening. Fertil Steril 101: 656–663.e651.
https://doi.org/10.1016/j.fertnstert.2013.11.004 PMID: 24355045
16. Nazemian Z, Esfandiari N, Javed M, Casper RF (2011) The effect of age on in vitro fertilization outcome:
is too young possible? J Assist Reprod Genet 28: 101–106. https://doi.org/10.1007/s10815-010-9499-
z PMID: 21042842
17. McCallie BR, Parks JC, Strieby AL, Schoolcraft WB, Katz-Jaffe MG (2014) Human blastocysts exhibit
unique microrna profiles in relation to maternal age and chromosome constitution. J Assist Reprod
Genet 31: 913–919. https://doi.org/10.1007/s10815-014-0235-y PMID: 24760722
18. Horcajadas JA, Riesewijk A, Polman J, van Os R, Pellicer A, Mosselman S, et al. (2005) Effect of con-
trolled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol Hum Reprod 11:
195–205. https://doi.org/10.1093/molehr/gah150 PMID: 15695772
19. Humaidan P, Van Vaerenbergh I, Bourgain C, Alsbjerg B, Blockeel C, Schuit F, et al. (2012) Endome-
trial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation
in recFSH stimulated and GnRH antagonist co-treated IVF cycles. Hum Reprod 27: 3259–3272.
https://doi.org/10.1093/humrep/des279 PMID: 22930004
20. Lee HJ, Jee BC, Suh CS, Kim SH, Moon SY (2012) Oocyte maturity in relation to woman’s age in in
vitro fertilization cycles stimulated by single regimen. Yonsei Med J 53: 181–185. https://doi.org/10.
3349/ymj.2012.53.1.181 PMID: 22187250
21. Chavez SL, Loewke KE, Han J, Moussavi F, Colls P, Munne S, et al. (2012) Dynamic blastomere
behaviour reflects human embryo ploidy by the four-cell stage. Nat Commun 3: 1251. https://doi.org/
10.1038/ncomms2249 PMID: 23212380
22. Davies S, Christopikou D, Tsorva E, Karagianni A, Handyside AH, Mastrominas M (2012) Delayed
cleavage divisions and a prolonged transition between 2-and 4-cell stages in embryos identified as
aneuploid at the 8-cell stage by array CGH. Hum Reprod 27: O–217.
23. Campbell A, Fishel S, Bowman N, Duffy S, Sedler M, Thornton S (2013) Retrospective analysis of out-
comes after IVF using an aneuploidy risk model derived from time-lapse imaging without PGS. Reprod
Biomed Online 27: 140–146. https://doi.org/10.1016/j.rbmo.2013.04.013 PMID: 23683847
24. Liu Y, Chapple V, Roberts P, Ali J, Matson P (2014) Time-lapse videography of human oocytes follow-
ing intracytoplasmic sperm injection: events up to the first cleavage division. Reprod Biol 14: 249–256.
https://doi.org/10.1016/j.repbio.2014.08.003 PMID: 25454490
25. Chiang T, Duncan FE, Schindler K, Schultz RM, Lampson MA (2010) Evidence that weakened centro-
mere cohesion is a leading cause of age-related aneuploidy in oocytes. Curr Biol 20: 1522–1528.
https://doi.org/10.1016/j.cub.2010.06.069 PMID: 20817534
26. Lister LM, Kouznetsova A, Hyslop LA, Kalleas D, Pace SL, Barel JC, et al. (2010) Age-related meiotic
segregation errors in mammalian oocytes are preceded by depletion of cohesin and Sgo2. Curr Biol 20:
1511–1521. https://doi.org/10.1016/j.cub.2010.08.023 PMID: 20817533
27. Hardarson T, Lofman C, Coull G, Sjogren A, Hamberger L, Edwards RG (2002) Internalization of cellu-
lar fragments in a human embryo: time-lapse recordings. Reprod Biomed Online 5: 36–38.
28. Lemmen JG, Agerholm I, Ziebe S (2008) Kinetic markers of human embryo quality using time-lapse
recordings of IVF/ICSI-fertilized oocytes. Reprod Biomed Online 17: 385–391. PMID: 18765009
29. Ziebe S, Lundin K, Loft A, Bergh C, Andersen AN, Selleskog U, et al. (2003) FISH analysis for chromo-
somes 13, 16, 18, 21, 22, X and Y in all blastomeres of IVF pre-embryos from 144 randomly selected
donated human oocytes and impact on pre-embryo morphology. Hum Reprod 18: 2575–2581. PMID:
14645173
30. Luzhna L, Kathiria P, Kovalchuk O (2013) Micronuclei in genotoxicity assessment: from genetics to epi-
genetics and beyond. Front Genet 4: 131. https://doi.org/10.3389/fgene.2013.00131 PMID: 23874352
31. Agerholm IE, Kolvraa S, Cruger DG, Berg C, Bruun-Petersen G, Ziebe S (2008) Resumption of mitosis
in frozen-thawed embryos is not related to the chromosomal constitution. Fertil Steril 90: 1649–1655.
https://doi.org/10.1016/j.fertnstert.2007.08.015 PMID: 18068161
Female age and embryo cleavage
PLOS ONE | https://doi.org/10.1371/journal.pone.0172456 April 19, 2017 12 / 12
